CONMED | CNMD - Gross Profit On Sales



CONMED reported $179M in Gross Profit on Sales for its fiscal quarter ending in September of 2024.

Gross Profit On Sales Change Date
3M USD 1.37B 1.31B Sep/2024
Abbott USD 5.94B 132M Sep/2024
AtriCure USD 86.79M 47K Sep/2024
Avanos Medical USD 92.9M 2.7M Sep/2024
Baxter International USD 1.03B 398M Sep/2024
Becton, Dickinson and Co. USD 2.52B 208M Sep/2024
Boston Scientific USD 2.89B 51M Sep/2024
CONMED USD 179M 4.73M Sep/2024
Cooper Companies USD 663M 31.8M Jul/2024
Dexcom USD 593.8M 32.9M Sep/2024
Edwards Lifesciences USD 1.09B 9.1M Sep/2024
Globus Medical USD 355.19M 14.46M Sep/2024
Hologic USD 607.5M 10.5M Sep/2024
Insulet USD 377.1M 46.2M Sep/2024
Integra LifeSciences USD 200.24M 25.68M Sep/2024
Intuitive Surgical USD 1.37B 1.2M Sep/2024
J&J USD 15.69B 108M Sep/2024
Masimo USD 263.2M 8.4M Sep/2024
Medtronic USD 5.17B 372M Jun/2024
Merit Medical Systems USD 157.54M 3.56M Sep/2024
Olympus JPY 166.75B 10.54B Sep/2024
ResMed USD 717.22M 6.29M Sep/2024
Smith & Nephew USD 987M 934M Jun/2024
Steris USD 578.79M 2.67M Sep/2024
Stryker USD 3.52B 39M Sep/2024
Tandem Diabetes Care USD 124.65M 11.86M Sep/2024
Teleflex USD 430.17M 13.71M Sep/2024
Zimmer Biomet Holdings USD 1.29B 103.1M Sep/2024